Fig. 17From: 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one (Abstract O17). Depletion studies reveal role of T cell subtypes. Mice were depleted of NK1.1+, CD4+, or CD8+ cells either throughout treatment with CS/IL-12 (a) or rechallenge at a distant site (b). Significant differences (P<0.05) in median survival by the Log-Rank test are indicated by *Back to article page